X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1668) 1668
Publication (89) 89
Book Review (5) 5
Magazine Article (5) 5
Newsletter (2) 2
Book Chapter (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1394) 1394
angiotensin-converting enzyme inhibitors - therapeutic use (1050) 1050
ramipril - therapeutic use (1037) 1037
male (915) 915
ramipril (784) 784
female (764) 764
middle aged (646) 646
hypertension - drug therapy (557) 557
index medicus (499) 499
aged (495) 495
antihypertensive agents - therapeutic use (480) 480
blood pressure - drug effects (374) 374
hypertension (370) 370
adult (358) 358
treatment outcome (351) 351
cardiac & cardiovascular systems (295) 295
risk factors (252) 252
drug therapy, combination (248) 248
animals (241) 241
pharmacology & pharmacy (241) 241
peripheral vascular disease (236) 236
double-blind method (217) 217
medicine, general & internal (203) 203
ramipril - pharmacology (198) 198
angiotensin-converting enzyme inhibitors - pharmacology (196) 196
mortality (194) 194
hypertension - physiopathology (191) 191
cardiovascular diseases - prevention & control (173) 173
benzimidazoles - therapeutic use (170) 170
ace inhibitors (168) 168
randomized controlled trials as topic (168) 168
angiotensin ii type 1 receptor blockers - therapeutic use (162) 162
ramipril - administration & dosage (161) 161
angiotensin-converting enzyme inhibitors - adverse effects (159) 159
rats (158) 158
blood-pressure (154) 154
ramipril - adverse effects (150) 150
blood pressure (147) 147
time factors (147) 147
benzoates - therapeutic use (146) 146
prospective studies (141) 141
hypertension - complications (139) 139
follow-up studies (134) 134
drug therapy (132) 132
renin-angiotensin system - drug effects (127) 127
telmisartan (127) 127
prevention (125) 125
angiotensin-converting enzyme inhibitors - administration & dosage (123) 123
heart-failure (122) 122
risk (122) 122
urology & nephrology (118) 118
cardiovascular events (115) 115
captopril (114) 114
disease (114) 114
heart failure - drug therapy (108) 108
trial (107) 107
angiotensin (106) 106
angiotensin-converting enzyme inhibitors (103) 103
myocardial-infarction (101) 101
cardiovascular diseases - drug therapy (100) 100
diabetes (100) 100
clinical trials as topic (97) 97
research (97) 97
tetrazoles - therapeutic use (90) 90
antihypertensive agents - pharmacology (88) 88
antihypertensive agents - adverse effects (87) 87
myocardial infarction - drug therapy (87) 87
antihypertensive agents - administration & dosage (86) 86
bridged bicyclo compounds - therapeutic use (84) 84
disease progression (83) 83
proteinuria (82) 82
nephropathy (81) 81
cardiovascular disease (80) 80
enzymes (80) 80
heart failure (80) 80
aged, 80 and over (77) 77
abridged index medicus (74) 74
prognosis (73) 73
progression (73) 73
renin-angiotensin system (73) 73
cardiovascular diseases (71) 71
care and treatment (71) 71
dose-response relationship, drug (71) 71
enalapril (69) 69
medicine & public health (68) 68
diabetes mellitus, type 2 - complications (65) 65
adolescent (64) 64
losartan (64) 64
retrospective studies (64) 64
therapy (63) 63
dosage and administration (62) 62
losartan - therapeutic use (62) 62
stroke - prevention & control (62) 62
atherosclerosis (61) 61
captopril - therapeutic use (60) 60
health aspects (60) 60
valsartan (60) 60
endocrinology & metabolism (59) 59
proteinuria - drug therapy (59) 59
adrenergic beta-antagonists - therapeutic use (58) 58
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1491) 1491
German (64) 64
Russian (36) 36
French (26) 26
Spanish (15) 15
Italian (11) 11
Hungarian (9) 9
Chinese (6) 6
Japanese (4) 4
Croatian (3) 3
Ukrainian (3) 3
Lithuanian (2) 2
Czech (1) 1
Dutch (1) 1
Finnish (1) 1
Hebrew (1) 1
Polish (1) 1
Portuguese (1) 1
Serbian (1) 1
Swedish (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


by Yusuf, S and Haridas, KK and Iyengar, SS and Jaison, TM and Joshi, P and Kerkar, P and Naik, S and Prabhakaran, D and Thanikachalam, S and Thomas, N and Parwani, J and Maseeh, A and Srinivasulu, B and Srinivas, J and Rangadham, K and Rayadurgee, NM and Balaji, Y and Bhavishya, Y and Parikh, K and Chag, M and Shah, U and Joseph, JJJ and Nesaraj, KJ and Malarvizhi, V and Patil, CB and Bantwal, G and Nagesh, H and Santosh, MI and Dwivedi, S and Ramesh, SS and Suresh, S and Ayyar, V and Rana, P and Tumari, DP and Agarwal, NB and Deshpande, N and Bhagchandani, R and Bhagchandani, S and Gupta, BK and Agarwal, DK and Panwar, RB and Bindu, AV and Alexander, KG and Pradeep, R and Nambiar, A and Das, CK and Ramu, M and Nayar, P and Poongothai, S and Mohan, V and Chidambaram, N and Diwan, R and Umarani, R and Bhuvaneswaran, JS and Mehta, A and Mittal, A and Sahwnay, JPS and Sidhu, G and Mehta, R and Singh, R and Bhambari, S and Rain, AR and Sastry, BKS and Rao, D and Karmalkar, M and Shah, PK and Govindaiah, P and Dharmi, S and Joshi, S and Gulla, SP and Rao, SP and Bharani, A and Patel, A and Mishra, BS and Chandwani, P and Gupta, R and Sreenivas, N and Reddy, SVR and Reddy, TVK and Kumar, V and Roy, DG and Paul, SK and Puri, A and Fisher, L and Sinha, N and Saxena, P and Kumar, S and Puri, VK and Modi, A and Thacker, HP and Mehta, K and Mehta, P and Srinivas, A and Guruprasad, HP and Bawangade, A and Khan, A and Jain, AS and Sane, D and Deshpande, M and Singh, H and ... and Indian Polycap Study (TIPS)
Lancet, The, ISSN 0140-6736, 2009, Volume 373, Issue 9672, pp. 1341 - 1351
Journal Article
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 04/2008, Volume 358, Issue 15, pp. 1547 - 1559
This large trial compared the angiotensin-receptor blocker telmisartan, the angiotensin-converting–enzyme inhibitor ramipril, and combination therapy with both... 
MEDICINE, GENERAL & INTERNAL | DESIGN | LEFT-VENTRICULAR DYSFUNCTION | MYOCARDIAL-INFARCTION | CARDIOVASCULAR EVENTS | DOUBLE-BLIND | SYSTOLIC DYSFUNCTION | RANDOMIZED CLINICAL-TRIALS | CONGESTIVE-HEART-FAILURE | COMBINATION | CONVERTING-ENZYME-INHIBITORS | Benzoates - adverse effects | Angiotensin II Type 1 Receptor Blockers - adverse effects | Benzoates - therapeutic use | Follow-Up Studies | Angiotensin II Type 1 Receptor Blockers - therapeutic use | Cardiovascular Diseases - drug therapy | Humans | Middle Aged | Male | Risk | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Angiotensin-Converting Enzyme Inhibitors - adverse effects | Cardiovascular Diseases - epidemiology | Cardiovascular Diseases - mortality | Female | Blood Pressure - drug effects | Ramipril - therapeutic use | Benzimidazoles - adverse effects | Drug Therapy, Combination | Ramipril - adverse effects | Benzimidazoles - therapeutic use | Double-Blind Method | Diabetes Mellitus - drug therapy | Kaplan-Meier Estimate | Hospitalization | Creatinine - blood | Angioedema - chemically induced | Aged | Complications and side effects | Ramipril | Drug therapy, Combination | Diabetes | Cardiovascular diseases | Drug therapy | Comparative analysis | Risk factors | Telmisartan | Clinical trials | Vein & artery diseases | Cardiovascular disease | Pharmacology | Clinical outcomes | Index Medicus | Abridged Index Medicus | Blood Pressure | Benzimidazoles | Cardiovascular Diseases | MEDICIN OCH HÄLSOVETENSKAP | Angiotensin II Type 1 Receptor Blockers | epidemiology | Angiotensin-Converting Enzyme Inhibitors | Combination | MEDICAL AND HEALTH SCIENCES | Creatinine | chemically induced | Benzoates | drug therapy | Angioedema | drug effects | Diabetes Mellitus | blood | adverse effects | mortality | therapeutic use | Kaplan-Meiers Estimate
Journal Article
European Journal of Heart Failure, ISSN 1388-9842, 08/2005, Volume 7, Issue 5, pp. 710 - 721
Surveys of prescribing patterns in both hospitals and primary care have usually shown delays in translating the evidence from clinical trials of... 
Heart failure | Isosorbide dinitrate | Beta‐blockers | Digoxin | Angiotensin receptor blockers | Pharmacology | Aldosterone antagonists | Treatment | Eplerenone | Spironolactone | Hydralazine | ACE inhibitors | Clinical recommendations | Beta-blockers | VENTRICULAR SYSTOLIC DYSFUNCTION | heart failure | treatment | CARDIAC & CARDIOVASCULAR SYSTEMS | angiotensin receptor blockers | QUALITY-OF-CARE | hydralazine | eplerenone | isosorbide dinitrate | RANDOMIZED INTERVENTION TRIAL | beta-blockers | MEDICAL-TREATMENT | GENERAL-PRACTICE | digoxin | spironolactone | CONVERTING-ENZYME-INHIBITORS | clinical recommendations | CARDIAC-INSUFFICIENCY | pharmacology | NATIONAL-SURVEY | aldosterone antagonists | ELDERLY-PATIENTS | Benzopyrans - therapeutic use | Valsartan | Angiotensin Receptor Antagonists | Bisoprolol - therapeutic use | Humans | Carbazoles - administration & dosage | Heart Failure - physiopathology | Valine - administration & dosage | Enalapril - therapeutic use | Ethanolamines - administration & dosage | Indoles - administration & dosage | Ramipril - administration & dosage | Captopril - therapeutic use | Propanolamines - therapeutic use | Lisinopril - therapeutic use | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Benzimidazoles - administration & dosage | Tetrazoles - administration & dosage | Ramipril - therapeutic use | Drug Therapy, Combination | Enalapril - administration & dosage | Spironolactone - therapeutic use | Adrenergic beta-Antagonists - administration & dosage | Adrenergic beta-Antagonists - therapeutic use | Benzimidazoles - therapeutic use | Lisinopril - administration & dosage | Nebivolol | Valine - analogs & derivatives | Metoprolol - therapeutic use | Metoprolol - administration & dosage | Evidence-Based Medicine | Angiotensin-Converting Enzyme Inhibitors - administration & dosage | Bisoprolol - administration & dosage | Heart Failure - drug therapy | Mineralocorticoid Receptor Antagonists - therapeutic use | Stroke Volume | Benzopyrans - administration & dosage | Captopril - administration & dosage | Guideline Adherence | Ethanolamines - therapeutic use | Indoles - therapeutic use | Metoprolol - analogs & derivatives | Tetrazoles - therapeutic use | Valine - therapeutic use | Carbazoles - therapeutic use | Propanolamines - administration & dosage | Practice Guidelines as Topic | Prescription writing | Corticosteroids | Isosorbide mononitrate | Family medicine | Nitrates | Peptide hormones | Aldosterone | Preventive health services | Cardiac patients | Angiotensin | Antiandrogens | Medicine, Preventive | Steroids | Kardiologi | converting-enzyme-inhibitors | Cardiac and Cardiovascular Systems | randomized intervention trial | quality-of-care | elderly-patients | cardiac-insufficiency | national-survey | medical-treatment | ventricular systolic dysfunction | general-practice
Journal Article
Lancet, The, ISSN 0140-6736, 2008, Volume 372, Issue 9638, pp. 547 - 553
Summary Background Angiotensin receptor blockers (ARB) and angiotensin converting enzyme (ACE) inhibitors are known to reduce proteinuria. Their combination... 
Internal Medicine | COOPERATE | MEDICINE, GENERAL & INTERNAL | METAANALYSIS | RENIN-ANGIOTENSIN SYSTEM | DISEASE | PROTEINURIA | CONVERTING ENZYME-INHIBITORS | COMBINATION | NEPHROPATHY | II RECEPTOR BLOCKERS | PROGRESSION | Benzoates - adverse effects | Angiotensin II Type 1 Receptor Blockers - adverse effects | Benzoates - therapeutic use | Follow-Up Studies | Angiotensin II Type 1 Receptor Blockers - therapeutic use | Cardiovascular Diseases - drug therapy | Humans | Middle Aged | Ramipril - administration & dosage | Proteinuria - chemically induced | Cardiovascular Diseases - complications | Glomerular Filtration Rate - drug effects | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Benzimidazoles - administration & dosage | Angiotensin-Converting Enzyme Inhibitors - adverse effects | Ramipril - therapeutic use | Benzimidazoles - adverse effects | Drug Therapy, Combination | Ramipril - adverse effects | Angiotensin II Type 1 Receptor Blockers - administration & dosage | Benzimidazoles - therapeutic use | Kidney - drug effects | Double-Blind Method | Diabetes Mellitus - drug therapy | Proteinuria - metabolism | Angiotensin-Converting Enzyme Inhibitors - administration & dosage | Creatinine - urine | Benzoates - administration & dosage | Creatinine - blood | Aged | Urine | Drugs | Studies | Kidneys | Disease | Clinical trials | Risk | ACE inhibitors | Index Medicus | Abridged Index Medicus
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 11/2013, Volume 369, Issue 20, pp. 1892 - 1903
Journal Article